Pol-driven replicative capacity impacts disease progression in HIV-1 subtype C infection.

CD8+ T cell mediated escape mutations in Gag can reduce HIV-1 replication capacity (RC) and alter disease progression, but less is known about immune-mediated attenuation in other HIV-1 proteins. We generated 487 recombinant viruses encoding RT-integrase from individuals with chronic (n = 406) and recent (n = 81) HIV-1 subtype C infection and measured their RC using a GFP-reporter T-cell assay. In recently-infected individuals, RT-integrase driven RC correlated significantly with viral load set point ( = 0.25; = 0.03) and CD4+ T cell decline ( = 0.013). Moreover, significant associations between RT-integrase driven RC and viral load ( = 0.28; <0.0001) and CD4+ T cell count ( =-0.29; <0.0001) remained in chronic infection. In early HIV infection, host expression of the protective HLA-B*81 allele was associated with lower RC ( = 0.05), as was expression of HLA-B*07 ( = 0.02), suggesting early immune-driven attenuation of RT-integrase by these alleles. In chronic infection, HLA-A*30:09 (in linkage disequilibrium with HLA-B*81) was significantly associated with lower RC (p=0.05), and all 6 HLA-B alleles with the lowest RC measurements represented protective alleles, consistent with long-term effects of host immune pressures on lowering RT-integrase RC. The polymorphisms V241I, I257V, P272K and E297K in reverse transcriptase and I201V in integrase, all relatively uncommon polymorphisms occurring in or adjacent to optimally-described HLA-restricted CTL epitopes, were associated with reduced RC. Together, our data suggest that RT-integrase-driven RC is clinically relevant, and provide evidence that immune-driven selection of mutations in RT-integrase can compromise RC. Identification of viral mutations that compromise HIV's ability to replicate may aid rational vaccine design. However, while certain escape mutations in Gag have been shown to reduce HIV replication and influence clinical progression, less is known about the consequences of mutations that naturally arise in other HIV proteins. Pol is a highly conserved protein but the impact of Pol function on HIV disease progression is not well-defined. Here we generated recombinant viruses using the RT-integrase region of Pol derived from HIV-1C infected individuals with recent and chronic infection and measured their ability to replicate We demonstrate that RT-integrase-driven replication ability significantly impacts HIV disease progression. We further show evidence of immune-mediated attenuation in RT-integrase and identify specific polymorphisms in RT-integrase that significantly decrease HIV-1 replication ability, suggesting which Pol epitopes could be explored in vaccine development.